Linaclotide has proven to be an important therapeutic advancement for the treatment of IBS and chronic constipation by stimulating secretion of chloride and bicarbonate into the intestinal lumen via activation of the CFTR ion channel, resulting in increased intestinal fluid secretion and accelerated GI transit [26]. This evidence concerns the gene CFTR and irritable bowel syndrome.